AstraZeneca PLC - American Depositary Shares (AZN)
Frequently Asked Questions About AstraZeneca PLC - American Depositary Shares (AZN)
How does AstraZeneca address access to medicines?
AstraZeneca aims to improve access to medicines by implementing innovative pricing strategies, forming partnerships with governments and healthcare organizations, and engaging in patient support programs. The company works to ensure that patients have timely access to its therapies, especially in under-served areas.
How does AstraZeneca engage with stakeholders?
AstraZeneca actively engages with stakeholders—including investors, healthcare professionals, patients, and regulatory authorities—to gather insights and inform its decision-making processes. The company places a strong emphasis on transparency and communication to build trust and foster collaboration.
How does AstraZeneca prioritize research and development?
AstraZeneca significantly invests in research and development (R&D), dedicating a substantial portion of its budget to the discovery of new treatments and therapies. The company emphasizes innovation by collaborating with academic institutions, biotechnology firms, and other organizations to propel advancements in medical science.
How has AstraZeneca adapted to the COVID-19 pandemic?
In response to the COVID-19 pandemic, AstraZeneca accelerated its vaccine development efforts and pivoted resources to address urgent healthcare needs. The company also implemented enhanced safety measures for its employees and adapted its operational practices to maintain business continuity during the crisis.
Is AstraZeneca involved in any partnerships?
Yes, AstraZeneca engages in multiple strategic partnerships with academic institutions, research organizations, and pharmaceutical companies. These collaborations aim to enhance drug discovery, share knowledge, and accelerate the development of new therapies within various therapeutic areas.
What are American Depositary Shares (ADS)?
American Depositary Shares (ADS) are a way for U.S. investors to buy shares in foreign companies. These shares represent a specific number of the company's foreign shares and are traded on U.S. exchanges, allowing investors to easily invest in international companies like AstraZeneca.
What are some major products developed by AstraZeneca?
AstraZeneca has developed several major pharmaceutical products, including the oncology drug Tagrisso, the diabetes medication Farxiga, and the respiratory drug Symbicort. The company has also gained prominence for its COVID-19 vaccine, Vaxzevria, developed in collaboration with the University of Oxford.
What awards or recognition has AstraZeneca received?
AstraZeneca has received various awards for its innovative research, corporate responsibility, and workplace culture. The company is often recognized in rankings such as Fortune's World's Most Admired Companies and the Dow Jones Sustainability Index for its commitment to ethics and sustainability.
What challenges does AstraZeneca face in the industry?
AstraZeneca faces several challenges, including regulatory hurdles, competition from generic and branded pharmaceuticals, and the need to navigate complex healthcare systems. Additionally, the company must continuously innovate to stay ahead in the rapidly evolving biopharmaceutical landscape.
What does AstraZeneca do?
AstraZeneca is a global biopharmaceutical company that develops and manufactures prescription medicines across a variety of therapeutic areas, including oncology, cardiovascular, renal, metabolism, respiratory, and autoimmune diseases. The company is known for its innovative drug development and commitment to improving patient outcomes.
What is AstraZeneca's commitment to patient-centered care?
AstraZeneca is dedicated to patient-centered care, focusing on understanding and addressing the needs of patients throughout the healthcare journey. The company's initiatives include providing patient education, support programs, and ensuring that its medicines are accessible and effective for those who need them.
What is AstraZeneca's role in vaccine development?
AstraZeneca played a key role in the development of a COVID-19 vaccine in partnership with the University of Oxford. The vaccine, known as Vaxzevria, was authorized for emergency use in multiple countries and has been a significant part of global vaccination efforts.
What is AstraZeneca’s approach to diversity and inclusion?
AstraZeneca promotes diversity and inclusion within its workforce and business practices, believing that a diverse workforce drives innovation. The company implements policies and programs aimed at ensuring equal opportunities for all employees while fostering an inclusive environment where everyone can thrive.
What is AstraZeneca’s commitment to sustainability?
AstraZeneca is committed to sustainability and environmental responsibility, aiming to reduce its carbon footprint and limit waste. The company has set ambitious targets for achieving net-zero greenhouse gas emissions by 2025 and is focused on creating sustainable practices across its operations.
What is AstraZeneca’s pipeline strategy?
AstraZeneca's pipeline strategy focuses on developing new and innovative therapies that address unmet medical needs. The company continually evaluates and prioritizes drug candidates at various stages of development, with a strong emphasis on precision medicine and combination therapies.
What is the ticker symbol for AstraZeneca on Nasdaq?
AstraZeneca's ticker symbol on Nasdaq is AZN. This symbol is used by investors and analysts to identify the company's stock in the U.S. financial markets.
What markets does AstraZeneca serve?
AstraZeneca serves a global market, with a presence in various regions including North America, Europe, Asia, and Latin America. The company’s products are distributed in over 100 countries, allowing it to cater to diverse patient populations with varying healthcare needs.
When was AstraZeneca founded?
AstraZeneca was formed in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group PLC. The merger combined their research and development capabilities, allowing them to enhance their portfolio of pharmaceuticals and expand their global reach.
Where is AstraZeneca headquartered?
AstraZeneca is headquartered in Cambridge, United Kingdom. The location is central to the company's strategic initiatives, as Cambridge is known for its strong ecosystem of academic and biotech research, facilitating collaborations and innovations in drug development.
What is the current price of AstraZeneca PLC - American Depositary Shares?
The current price of AstraZeneca PLC - American Depositary Shares is 74.30
When was AstraZeneca PLC - American Depositary Shares last traded?
The last trade of AstraZeneca PLC - American Depositary Shares was at 2:52 pm EDT on April 3rd, 2025